A Study to Collect Ovarian Tissue from Girls Undergoing Fertility-preserving Cryopreservation

Overview

About this study

The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients and other female patients whose future fertility will be affected due to a disease or treatment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Be female, age 0-17 years.
  • Be undergoing an elective laparoscopic oophorectomy or oophorectomy done via laparoscopy as part of their clinical care.
  • Sign an approved informed consent and authorization permitting the release of personal health information. The patient and/or the patient’s legally authorized guardian must acknowledge in writing that consent for specimen collection has been obtained, in accordance with institutional policies approved by the U.S. Department of Health and Human Services.

Exclusion Criteria: 

  • Girls with psychological, psychiatric, or other conditions which prevent giving fully informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Zaraq Khan, M.B.B.S.

Open for enrollment

Contact information:

Supriya Behl CCRP

(507) 538-1440

Behl.Supriya@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20492626

Mayo Clinic Footer